Carlo Montemagno

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Carlo Montemagno
Born(1956-08-07)August 7, 1956
DiedOctober 11, 2018(2018-10-11) (aged 62)
ResidenceUnited States
NationalityUnited States
Alma materCornell University, Pennsylvania State University, University of Notre Dame
AwardsFeynman Prize in Nanotechnology (2003)
Earth Award Grand Prize
CNBC Business Top 10 Green Innovators award
Bill & Melinda Gates Grand Challenge Winner
Scientific career
FieldsBiomedical Engineering, Nanotechnology, Bionanotechnology
InstitutionsUniversity of California, Los Angeles, Cornell University, University of Chicago, University of Alberta, Argonne National Laboratory, University of Cincinnati, Southern Illinois University Carbondale
Doctoral advisorWilliam Gray

Carlo Montemagno (August 7, 1956 – October 11, 2018) was an American engineer and expert in nanotechnology and biomedical engineering, focusing on futursitic technologies to create interdisciplinary solutions for the grand challenges in health, energy and the environment. He has been considered as one of the pioneers of bionanotechnology; some of his fundamental contributions include the development of biomolecular motors for powering inorganic nanodevices while at Cornell[1] and muscle-driven self-assembled nanodevices while at UCLA.[2]

Academic career[edit]

Montemagno received his bachelor’s degree in Agricultural and Biological Engineering from Cornell University in New York, his master’s degree in Petroleum and Natural Gas Engineering from Pennsylvania State University, and his doctoral degree in Civil Engineering and Geological Sciences from the University of Notre Dame in Indiana.[3]

Montemagno died in office while serving as the Chancellor of Southern Illinois University Carbondale. Right before moving to SIU, he directed the interdisciplinary Ingenuity Lab at the University of Alberta in Edmonton, Canada, he also served as the Director of the Biomaterials Program for the Canadian Research Council’s National Institute for Nanotechnology as well as a Strategic Research Chair in Intelligent Nanosystems for the National Research Council. Before joining the University of Alberta, he was the Founding Dean of the College of Engineering and Applied Sciences at the University of Cincinnati.

His previous academic appointments include being the Founding Chair of the Department of Bioengineering and Biomedical Engineering, Co-Director of the NASA Center for Cell Mimetic Space Exploration, and Associate Director of the California Nanosystems Institute at the University of California, Los Angeles, the Director of the Biomedical Engineering Graduate Program at Cornell University and the Group Leader in Environmental Physics at the Argonne National Laboratory in Chicago, he also served in the U. S. Navy Civil Engineer Corps for nine years.[3]

Awards and honors[edit]

Throughout his career, Montemagno received many awards for his scientific innovations, including the Feynman Prize in Nanotechnology (for creating single molecule biological motors with nano-scale silicon devices), the Earth Award Grand Prize (for cell-free artificial photosynthesis with over 95% efficiency) and the CNBC Business Top 10 Green Innovators award (for Aquaporin Membrane water purification and desalination technology), he was named a Bill & Melinda Gates Grand Challenge Winner for his development of an oral vaccine delivery system that increased vaccine stability. He was a Fellow for the American Institute for Medical and Biomedical Engineering, the American Academy for Nanomedicine and the NASA Institute for Advanced Concepts.[3]

Personal life[edit]

Carlo Montemagno was born in 1956 to Gasper Patrick and Jacqueline Ann (Graham) Montemagno in Bronx, NY, he married Pamela Ann LaCava in 1976, who would be his wife until his death. He was an avid reader and collector of books and an aerobatic and commercial pilot, he also enjoyed dog sports, falconry, ice climbing, science fiction, war movies and disco. Montemagno died in 2018 in St. Louis due to complications arising from cancer.[4]

References[edit]

  1. ^ Montemagno, Carlo D.; Craighead, Harold G.; Olkhovets, Anatoli G.; Neves, Hercules P.; Bachand, George D.; Soong, Ricky K. (24 November 2000). "Powering an Inorganic Nanodevice with a Biomolecular Motor". Science. 290 (5496): 1555–1558. doi:10.1126/science.290.5496.1555. PMID 11090349 – via science.sciencemag.org.
  2. ^ Wong, David T. W.; Abemayor, Elliot; Liu, Honghu; Park, No-Hee; Wolinsky, Lawrence; Jordan, Richard; Sinha, Uttam; Wu, Benjamin; Qi, Fengxia; Shi, Wenyuan; Montemagno, Carlo; Ho, Chih-Ming; Denny, Paul; Zhou, Xiaofeng; Li, Yang; John, Maie A. R. St (1 August 2004). "Interleukin 6 and Interleukin 8 as Potential Biomarkers for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma". Archives of Otolaryngology–Head & Neck Surgery. 130 (8): 929–935. doi:10.1001/archotol.130.8.929. PMID 15313862 – via jamanetwork.com.
  3. ^ a b c Rhodes, Dawn. "SIU Chancellor Carlo Montemagno dies at 62". chicagotribune.com.
  4. ^ "Dr. Carlo David Montemagno Obituary - Visitation & Funeral Information". www.meredithfh.com.

External links[edit]